Ryan Lafferty

Chief Executive Officer

Dia Beta Labs leverages over 30 years of groundbreaking research from Ulster University to develop next-gen therapeutics for metabolic diseases, addressing the global diabetes and obesity crisis, which affects over 537 million adults worldwide, with Type 2 Diabetes making up over 90% of cases.